Robotics Surgery Funding in the last 12 months was USD 1b+: Retrospective Analysis of the sector from March 2023 until March 2024

What happened in terms of funding between 2023 and now?

Biobot Surgical Group secures $18M Series B for Mona Lisa surgical robot in March 2024.

A Singapore based company has successfully finished B round funding round of 18m USD. The Series B funding will allow BIOBOT to grow its global footprint and enhance its digital surgery infrastructure. The Mona Lisa device stands out as the initial and sole robotics-assisted transperineal needle positioning device available on the market.

MMI - Medical Microinstruments, Inc. secures $110M and more digital health fundings in February 2024. Medical Microinstruments, a surgical robotics company, announced it secured $110 million in a Series C financing round led by Fidelity Management & Research Company, with participation from existing investors. The company offers its Symani Surgical System, a robotic technology for microsurgery and supermicrosurgery. The system allows surgeons to replicate the movement of a human hand at a micro level during soft tissue and open surgery procedures. The Florida-based company will use the funds to support the commercialization of its robotic system and perform clinical studies.

LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission in January 2024.

An innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors' confidence in LEM Surgical's differentiated approach.

Dental robotics company Neocis raises $20M in January 2024.

Neocis, maker of surgical technology for robot-assisted dental implants, announced today that it raised $20 million in additional funding.Maimi-based Neocis received investments from Mirae Asset Capital/Mirae Asset Venture Investment. They have an affiliation with the Mirae Asset Financial group and invest in growth-stage healthcare and technology businesses. NVentures, NVIDIA’s venture capital arm, also participated in the funding.

Lithuanian medtech startup Sentante secures €6M for its teleoperated robotics in December 2023.

Intuitive’s VC arm closes second fund with $150M for minimally invasive care startups in?December 2023.

Three years after launching with a first fund of $100 million, Intuitive Surgical’s venture capital arm has gone even bigger with its second funding pool. ?The aptly named Fund II has closed with $150 million in new VC dollars to dole out, Intuitive Ventures said in a Monday announcement.

EndoQuest Robotics Robotics Closes $42 Million in Financing to Advance Endoluminal Robotics Technology

EndoQuest Robotics, Inc., (the "Company") a privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, announced on the 4th of December 2023 the successful closure of a $42 million C-1 preferred financing round. ?

VISIE Inc. ., Formerly Advanced Scanners, Raises $8.2M?to Make the Unseen Seen in Orthopedic, Neuro, and Spine Surgery in?November 2023.

VISIE Inc., formerly known as Advanced Scanners, announces it has raised $8.2M in an oversubscribed Series A funding round to further its mission of making the unseen seen in surgery.

Microsure raises $40M to advance microsurgical robot.

Microsure announced in October 2023 that it successfully closed its Series B2 investment round, securing nearly $40 million (€38 million).Eindhoven, The Netherlands-based Microsure plans to use the funds to finalize the development of its newest microsurgical robot. It intends to progress its MUSA-3 robot through clinical studies, then subsequent FDA clearance and CE mark approval.

CMR Surgical has raised 165 million USD in 2023 continuing development of its Versius surgical robot in September 2023.

Versius (CMR Robot) recently passed the milestone of 15,000 surgeries and is used in over 20 countries across a range of specialisms.

Virtual Incision adds $30M in funding for miniaturized surgical robot.

Virtual Incision announced in September 2023 that it added a $30 million extension to its previous $46 million Series C financing round.

Virtual Incision designed its MIRA surgical system to address the limitations of traditional robotic-assisted mainframe machines. It miniaturized and simplified the soft tissue robotics platform to make it more accessible, easy to use, and easy to adopt.

瑞龙诺赋（上海）医疗科技有限公司 raises $26M for surgical robot platform in September 2023. Ronovo Surgical announced its second successful fundraising round in the past eight months, bringing in $26 million to support its surgical robot. Shanghai, China-based Ronovo closed a funding round in February, also unveiling its Carina surgical robotic platform. The $26 million in the latest round brings the company’s total fundraising to more than $76 million since 2020.

Galen Robotics Inc., a leading medtech company specializing in advanced robotic surgical systems, in September 2023 announced U.S. Food and Drug Administration (FDA) De Novo classification grant and authorization to market the Galen ES? Robotic System for use in rigid microlaryngeal procedures. This milestone achievement marks a significant step in Galen Robotics' mission to meet underserved markets with its surgical robotic assistant.

The Galen ES is a cooperatively powered surgical assist device for ear, nose, and throat (ENT) surgery. It facilitates ENT surgical procedures, including instrument placement in conjunction with Microlaryngeal Alligator Forceps. The device works in partnership with the surgeon's movements to assist with precise and stable positioning of an instrument while maintaining the surgeon's direct physical control of the instrument.

Virtuoso Surgical, Inc. ?adds $1.8M in grant funding to support surgical robot?

Virtuoso designed its system with two robotically controlled, needle-sized manipulators working from the tip of a rigid endoscope. That endoscope comes in at less than half the diameter of a U.S. dime.

Microbot Medical ?gets IIA grant for endovascular surgical robotic system in June 2023.

Pre-clinical medical device company Microbot Medical has received funding worth NIS1.62m ($440,000) from the Israel Innovation Authority (IIA) for its endovascular surgical robotic system LIBERTY.

Moon Surgical raises $55.4m for robotics system in May 2023. Moon Surgical has an FDA cleared Maestro system. Maestro augments surgical procedures by aiding surgeons carrying out laparoscopies and is compatible with standard laparoscopic cameras and instruments and offers a more affordable alternative to current robotic options

Moon Surgical has secured $55.4m in venture funding co-led by Sofinnova Partners, through its Sofinnova Capital Strategy, and NVIDIA’s venture capital arm, NVentures. The funding adds to a previous $31.3m Series A funding completed in June 2022.

Noah Medical raises $150M Series B for surgical robot platform in April 2023

San Carlos, California-based Noah Medical plans to use the funds to support its Galaxy System as demand increases. The company received FDA clearance for Galaxy for robotic-navigated bronchoscopy last year in March 2023. Galaxy and its accessories provide bronchoscopic visualization and access. These capabilities provide diagnostic and therapeutic procedures in patient airways. The system features advanced imaging technologies that provide real-time location updates for potentially cancerous lesions. Noah says it designed the technology to improve tool-in-lesion and diagnostic yield.

Distalmotion brings in $150M as it seeks FDA nod for surgical robot in April 2023.

Distalmotion announced today that it closed a $150 million financing as it looks to bring its surgical robot to the U.S. market. Revival Healthcare Capital led the financing round. Distalmotion said in a news release that the funds reinforce the confidence of its existing investors.

Stan Kalinin draws on an extensive track record of more than 14 years of search and executive team-building expertise. He is the host of MedTech Opinion Leader supporting growth of MedTech industry and creating insightful stories with key market executives forging alternative narrative about the sector current and future trends.